top of page

Chief Financial Officer (CFO)

Mr. Edmund Hen

Chief Financial Officer (CFO) of

YD Biopharma

Mr. Edmund Hen is a seasoned financial expert with over two decades of experience in corporate finance, capital markets, and business strategy. As the Chief Financial Officer (CFO) at YD Biopharma, he brings extensive knowledge of financial management, regulatory compliance, and business development. His leadership has been instrumental in guiding the company through significant growth and market expansion.

At YD Biopharma, we understand the importance of sound financial management in driving sustainable growth. Through collaboration, innovation, and disciplined financial strategy, we continue to empower the company to deliver life-changing solutions to our patients and stakeholders.

Screenshot 2025-01-24 at 3.28.55 PM.png

Academic Excellence

Master of Science in Professional Accounting, University College London, UK

Bachelor of Science in Accounting and Finance, University of East Anglia, UK

畢業慶典

Professional Achievements

Led the IPO process for several companies, including roadshows, secondary offerings, and bond offerings.

Oversaw the resolution of halted stock trading and legal class actions, maintaining investor confidence.

Managed M&A activities, investor relations, and corporate finance for companies listed on U.S. and international capital markets.

Instrumental in expanding companies’ operations across multiple regions, including China and Southeast Asia.

新加坡

Professional Experience

CFO, XXXX Holdings Ltd (NASDAQ: XXX) (2008 – Present)

CFO, Sichuan Guanglin Electric Co., Ltd. (2006 – 2008)

CFO, Guanhong (China) Limited (2005 – 2006)

Accounting Manager, Dickson Concepts Limited (2002 – 2005)

Internal Auditor, PRG Profits Recovery Ltd (2000 – 2002)

Auditor, Arthur Anderson, Hong Kong (1995 – 2000)

處理財務文件

Vision and Leadership

Mr. Hen's leadership in finance, coupled with his extensive experience in the capital markets, plays a key role in steering YD Biopharma toward continued growth and success. His strategic financial oversight ensures that the company remains at the forefront of innovation and global healthcare solutions.

Image by Joshua Earle
bottom of page